- Home
- CCCC vs MBI Comparison
CCCC vs MBI Comparison
Compare CCCC & MBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- MBI
- Stock Information
- Founded
- CCCC 2015
- MBI 1973
- Country
- CCCC United States
- MBI United States
- Employees
- CCCC N/A
- MBI N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- MBI Property-Casualty Insurers
- Sector
- CCCC Health Care
- MBI Finance
- Exchange
- CCCC Nasdaq
- MBI Nasdaq
- Market Cap
- CCCC 104.4M
- MBI 220.1M
- IPO Year
- CCCC 2020
- MBI 1987
- Fundamental
- Price
- CCCC $1.43
- MBI $4.33
- Analyst Decision
- CCCC Buy
- MBI Buy
- Analyst Count
- CCCC 3
- MBI 2
- Target Price
- CCCC $12.00
- MBI $6.25
- AVG Volume (30 Days)
- CCCC 1.3M
- MBI 191.9K
- Earning Date
- CCCC 07-31-2025
- MBI 08-05-2025
- Dividend Yield
- CCCC N/A
- MBI N/A
- EPS Growth
- CCCC N/A
- MBI N/A
- EPS
- CCCC N/A
- MBI N/A
- Revenue
- CCCC $39,783,000.00
- MBI $37,000,000.00
- Revenue This Year
- CCCC N/A
- MBI N/A
- Revenue Next Year
- CCCC N/A
- MBI N/A
- P/E Ratio
- CCCC N/A
- MBI N/A
- Revenue Growth
- CCCC 98.56
- MBI 285.71
- 52 Week Low
- CCCC $1.09
- MBI $3.22
- 52 Week High
- CCCC $7.66
- MBI $7.46
- Technical
- Relative Strength Index (RSI)
- CCCC 50.43
- MBI 47.19
- Support Level
- CCCC $1.36
- MBI $4.22
- Resistance Level
- CCCC $1.63
- MBI $4.45
- Average True Range (ATR)
- CCCC 0.14
- MBI 0.15
- MACD
- CCCC -0.00
- MBI 0.01
- Stochastic Oscillator
- CCCC 38.10
- MBI 50.00
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.